Global Healthcare Costs Surge Amid West Asia Conflict and Supply Chain Disruptions

Highlights:

• Healthcare costs are increasing due to increasing input, energy and logistics expenses
• Supply chain disruptions are creating sustained global healthcare inflation
• Pharmaceutical production and medical supply delivery are experiencing major breakdown strategies to navigate an increasingly volatile landscape

Global Healthcare Costs are Rising Amid West Asia Conflict

Surging geopolitical tensions in West Asia, particularly involving the United States, Israel and Iran, are putting pressure on global healthcare systems. The conflict is making healthcare more expensive and unsettling the flow of essential medicines and medical supplies.

Key trade routes and energy markets are in turmoil, accelerating healthcare cost pressures, affecting both developed and emerging economies.  

Supply Chain Distractions Driving Healthcare Inflation

Global healthcare inflation is being fuelled by persistent supply chain delays. Key logistics hubs in the Gulf region have witnessed severe disruptions, with airport operations dropping by as much as 80% in some cases.

This leads to shortages and stock gaps through:

• 10–20 days extended transit times
• 2–3 times increased freight costs

As a result, healthcare providers and manufacturers are facing sustained pricing pressure.

Impact on India’s Pharmaceutical Sector

India’s healthcare and pharmaceutical sector is dealing with much higher raw material costs.

• Prices of plastic for medical and surgical equipment have increased by 50–60%
• Medicine and medical equipment prices are expected to rise by 20–25%
• Medical consumables may see 10–20% increases starting April 2026

These cost increases are directly linked to the slowdown in petrochemical supply chains and higher logistics expenses.

Mounting API Production and Energy Costs

At the pharmaceutical manufacturing level, the costs are becoming difficult to manage.

Energy accounts for 15–25% of pharmaceutical manufacturing costs, making the sector heavily dependent on oil prices. Closures and disruptions of key trade routes such as the Strait of Hormuz are pushing up oil prices and, in turn, pharmaceutical manufacturing costs.

This is the direct result of the following:

• Freight costs have increased significantly
• Postponements in petrochemical input shipments are affecting production cycles

Moreover, supplier profit margins are shrinking due to growing operational costs.

Global Impact on Healthcare Systems

• Europe’s Manufacturing Cost Surge: In Europe, healthcare manufacturing input prices have reached their highest levels since October 2022This is driven by supply chain issues and energy price increases linked to the ongoing conflict.
• Humanitarian and Supply Challenges in Iran: In Iran, rising casualties have increased demand for healthcare services, while supply shortages have worsened due to disrupted logistics. Humanitarian organisations report critically low availability of essential medical supplies.

The Push for Stronger Healthcare Supply Chains

The current crisis points toward the urgent need for more resilient and diversified healthcare supply chains. Relying on limited trade routes and imported raw materials could prove to be the healthcare sector’s undoing during the current time of crisis.

In order to avert supply chain issues, the focus needs to shift to diversifying the supply chain, including scouring alternative logistics routes, promoting localized manufacturing capabilities and strategic inventory management.